Article metrics

Download PDFPDF
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

 

Online download statistics by month:

Online download statistics by month: March 2019 to June 2024

AbstractFullPdf
Mar 20191600
Apr 20191000
May 20191801
Jun 2019800
Jul 2019400
Aug 2019600
Sep 2019200
Oct 2019400
Nov 2019400
Dec 2019700
Jan 20201000
Feb 2020600
Mar 20204200
Apr 20201400
May 20201000
Jun 2020800
Jul 20204400
Aug 20203400
Sep 20204400
Oct 20209600
Nov 202010402
Dec 20202001
Jan 20212000
Feb 20211000
Mar 20211000
Apr 2021600
May 2021100
Jul 2021004
Oct 20211000
Nov 2021800
Dec 20211400
Jan 20221801
Feb 20221600
Mar 20221701
Apr 2022800
May 20225000
Jun 20223200
Jul 20221401
Aug 20223000
Sep 20222601
Oct 20225400
Nov 20222000
Dec 20222400
Jan 20231300
Feb 20234500
Mar 2023800
Apr 2023400
May 2023600
Jun 2023600
Jul 20231100
Aug 2023900
Sep 20231400
Oct 20231000
Nov 2023800
Dec 20232000
Jan 20241200
Feb 20241200
Mar 20242000
Apr 20242500
May 20242401
Jun 20241600
Total1162013